Regression of choroidal neovascularization in response to systemic chemotherapy for cancer

Can J Ophthalmol. 2013 Aug;48(4):e80-2. doi: 10.1016/j.jcjo.2013.02.004.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Transitional Cell / drug therapy*
  • Carcinoma, Transitional Cell / pathology
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / physiopathology
  • Cisplatin / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Docetaxel
  • Fatal Outcome
  • Fluorescein Angiography
  • Gemcitabine
  • Humans
  • Male
  • Remission Induction
  • Taxoids / administration & dosage
  • Tomography, Optical Coherence
  • Urethral Neoplasms / drug therapy*
  • Urethral Neoplasms / pathology
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Taxoids
  • Deoxycytidine
  • Docetaxel
  • Cisplatin
  • Gemcitabine